Stock BLCO BAUSCH + LOMB CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Bausch + Lomb Corporation Toronto S.E.

Equities

BLCO

CA0717051076

Market Closed - Toronto S.E.
Other stock markets
 11:35:08 19/06/2024 pm IST 		5-day change 1st Jan Change
20.37 CAD +1.19% Intraday chart for Bausch + Lomb Corporation +0.10% -10.15%
17/06 Bausch + Lomb Brief: To Present New Data at European Dry Eye Society 2024 Congress; Events Include Symposium on Patient-Centric Approaches to Dry Eye, "Highlighting Breakthroughs in Diagnosis, Treatment and Care" MT
10/06 Bausch + Lomb Corporation Announces the U.S. Introduction of Bausch + Lomb Infuse for Astigmatism Daily Disposable Contact Lenses CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bausch + Lomb Brief: To Present New Data at European Dry Eye Society 2024 Congress; Events Include Symposium on Patient-Centric Approaches to Dry Eye, "Highlighting Breakthroughs in Diagnosis, Treatment and Care"
MT
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
BU
Bausch + Lomb Corporation Announces the U.S. Introduction of Bausch + Lomb Infuse for Astigmatism Daily Disposable Contact Lenses
CI
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
BU
Bausch + Lomb Brief: Launching "Clinically Proven" Nutritional Supplement for Dry Eyes in the United States
MT
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
BU
Bausch + Lomb Corporation Launches Blink? NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
CI
Bausch + Lomb Corporation Approves Election of Gary Hu as Director
CI
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
BU
Bausch + Lomb Receives Health Canada Approval for enVista Envy Full Visual Range Intraocular Lens
AQ
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry's Meeting
AQ
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®
BU
Bausch + Lomb's New Intraocular Lens Approved by Health Canada
MT
Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens
MT
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
BU
Bausch + Lomb Corporation Receives Health Canada Approval for Envista Envy?? Full Visual Range Intraocular Lens
CI
Bausch Health Companies - Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
AQ
Bausch Health Announces 2024 Annual Meeting of Shareholder Results
AQ
Bausch + Lomb : 2023 Report
PU
Bausch + Lomb Shares Rise After Morgan Stanley Upgrade
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLCO Stock
  4. BLCO Stock
  5. News Bausch + Lomb Corporation